2nd Quarter - Report

W STRATEGIES, LLC for HORIZON PHARMA USA, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Education and outreach regarding access to therapies for rare diseases. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures). Issues related to FDA drug approvals, specifically for orphan disease products.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.